These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. Zhang W; Zhang S; Deng Y; Wu S; Ren J; Sun G; Yang J; Jiang Y; Xu X; Wang TD; Chen Y; Li Y; Yao L; Li D; Wang L; Shen X; Yin X; Liu W; Zhou X; Zhu B; Guo Z; Liu H; Chen X; Feng Y; Tian G; Gao X; Kario K; Cai J; N Engl J Med; 2021 Sep; 385(14):1268-1279. PubMed ID: 34491661 [TBL] [Abstract][Full Text] [Related]
6. Effects of intensive blood-pressure control in type 2 diabetes mellitus. ; Cushman WC; Evans GW; Byington RP; Goff DC; Grimm RH; Cutler JA; Simons-Morton DG; Basile JN; Corson MA; Probstfield JL; Katz L; Peterson KA; Friedewald WT; Buse JB; Bigger JT; Gerstein HC; Ismail-Beigi F N Engl J Med; 2010 Apr; 362(17):1575-85. PubMed ID: 20228401 [TBL] [Abstract][Full Text] [Related]
7. Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial. Liu J; Li Y; Ge J; Yan X; Zhang H; Zheng X; Lu J; Li X; Gao Y; Lei L; Liu J; Li J; Lancet; 2024 Jul; 404(10449):245-255. PubMed ID: 38945140 [TBL] [Abstract][Full Text] [Related]
8. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial. Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803 [TBL] [Abstract][Full Text] [Related]
9. Blood pressure targets in adults with hypertension. Arguedas JA; Leiva V; Wright JM Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004349. PubMed ID: 33332584 [TBL] [Abstract][Full Text] [Related]
10. Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT. Juraschek SP; Taylor AA; Wright JT; Evans GW; Miller ER; Plante TB; Cushman WC; Gure TR; Haley WE; Moinuddin I; Nord J; Oparil S; Pedley C; Roumie CL; Whittle J; Wiggers A; Finucane C; Anne Kenny R; Appel LJ; Townsend RR; Hypertension; 2020 Mar; 75(3):660-667. PubMed ID: 31983312 [TBL] [Abstract][Full Text] [Related]
12. Association of Acute Kidney Injury with Cardiovascular Events and Death in Systolic Blood Pressure Intervention Trial. Dieter BP; Daratha KB; McPherson SM; Short R; Alicic RZ; Tuttle KR Am J Nephrol; 2019; 49(5):359-367. PubMed ID: 30939480 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg. Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663 [TBL] [Abstract][Full Text] [Related]
14. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A Lancet; 2016 Jan; 387(10017):435-43. PubMed ID: 26559744 [TBL] [Abstract][Full Text] [Related]
15. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. Lonn EM; Bosch J; López-Jaramillo P; Zhu J; Liu L; Pais P; Diaz R; Xavier D; Sliwa K; Dans A; Avezum A; Piegas LS; Keltai K; Keltai M; Chazova I; Peters RJ; Held C; Yusoff K; Lewis BS; Jansky P; Parkhomenko A; Khunti K; Toff WD; Reid CM; Varigos J; Leiter LA; Molina DI; McKelvie R; Pogue J; Wilkinson J; Jung H; Dagenais G; Yusuf S; N Engl J Med; 2016 May; 374(21):2009-20. PubMed ID: 27041480 [TBL] [Abstract][Full Text] [Related]